COVID-19 Cellular Immune Responses


Wednesday, May 27, 2020


10:00 AM Europe/Berlin

convert to my timezone
This event is certified, please provide correct information.
This field is required. Double-check the spelling.
This field is required. Double-check the spelling.
This field is required. Double-check the spelling.
This field is required. Double-check the spelling.
Required fields
If you have already registered and can't locate your registration confirmation email,click here!
The email address is incorrect. Please double-check your email address.

A confirmation email with logging details has been sent to the provided email.

System configuration test. Click here!


Coronavirus (COVID-19) in Australia: being prepared and understanding the role of cellular immune responses

What role do cellular immune responses play in squashing the curve of COVID-19 infections? Sharon Lewin and Katherine Kedzierska will show how immunity to SARS-CoV2 has demonstrated the breadth of concomitant immune responses associated with recovery in patients with mild to moderate COVID-19 requiring hospitalisation. Their study indicates that robust multi-factorial immune responses can be elicited towards the newly-emerged SARS-CoV-2 and early adaptive immune responses might correlate with better clinical outcomes.


Sharon Lewin

Infectious diseases physician and basic scientist Sharon Lewin is the inaugural director of the Peter Doherty Institute for Infection and Immunity.
She is the lead investigator for the Australian Partnership for Preparedness Planning on Infectious Disease Emergencies (APPRISE). She is a member of the scientific advisory board for the Agence National du Recherche de SIDA and the Vaccine Research Centre at the National Institutes for Health, Bethesda MD.

Katherine Kedzierska

Katherine Kedzierska is Laboratory Head in Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity.
 Her research interests include human T cell immunity to pandemic, seasonal and newly emerged influenza viruses, anti-viral immunity in the young, the elderly and Indigenous Australians, viral escape and generation of immunological memory in human influenza infection. She also studies human immunity to SARS-CoV2 in COVID patients

Roslyn Kemp

Roslyn Kemp is the Past President of the New Zealand Society for Oncology and Secretary-General of IUIS.
She has a background in fundamental T cell biology in the context of homeostasis and cancer. Her current work focuses on the local immune response in people with colorectal cancer and inflammatory bowel diseases.